Product Information
ADDERALL XR 5 MG CAPSULE is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $6.8275 per EA under NDC 54092038101. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Oct 11, 2001. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
ADDERALL XR 5 MG CAPSULE
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate and Amphetamine AspartateStrength
1.25; 1.25; 1.25; 1.25 mg/1; mg/1; mg/1; mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
54092038101
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
New Drug (NDA)
FDA Application
NDA021303FDA Approved
10/11/2001
TE Code
AB1
On Market Since
5/22/2002
Pharmacological Classes
Price Statistics
The NADAC for ADDERALL XR 5 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.8275 per EA |
|---|---|
| All-time high | $6.9795 (Mar 16, 2016) |
| All-time low | $6.8077 (Mar 18, 2026) |
| 52-week high | $6.8275 |
| 52-week low | $6.8077 |
| Median price | $6.8383 |
| Average price | $6.8535 |
| Largest weekly change | -1.8% (Mar 23, 2016) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 93% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ADDERALL XR 5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ADDERALL XR 5 MG CAPSULE, manufactured by Takeda Pharmaceuticals America, Inc., is $6.8275 per EA (NDC 54092038101), effective Aug 19, 2026.
How has the price of ADDERALL XR 5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ADDERALL XR 5 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ADDERALL XR 5 MG CAPSULE?
Since Nov 28, 2013, the NADAC for ADDERALL XR 5 MG CAPSULE has ranged from a low of $6.8077 (Mar 18, 2026) to a high of $6.9795 (Mar 16, 2016), with a median of $6.8383 per EA.
Are there cheaper alternatives to ADDERALL XR 5 MG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXTROAMP-AMPHET ER 5 MG CAP, is $0.4793 per EA — about 93% below ADDERALL XR 5 MG CAPSULE.
Who manufactures ADDERALL XR 5 MG CAPSULE?
ADDERALL XR 5 MG CAPSULE (NDC 54092038101) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.